Roche Receives CE Mark for Tuberculosis Blood Test
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
Read MorePosted by CLP Edit Staff | Jul 13, 2026 | Immunoassay, Infectious Diseases, Lab Automation |
The automated assay identifies latent infections in routine laboratory settings with results available in less than 24 hours.
Read MorePosted by CLP Edit Staff | Jul 2, 2026 | Infectious Diseases |
IntelliGenome receives regulatory clearance and partners with Velez Lab for distribution of its molecular diagnostic assay.
Read MorePosted by CLP Edit Staff | Jun 2, 2026 | Sexually Transmitted Diseases |
The facility will support the clinical validation of diagnostic kits that provide results via a mobile app without the need for laboratory processing.
Read MorePosted by CLP Edit Staff | May 28, 2026 | Compliance, Lab Management, Molecular Diagnostics |
The settlement follows a criminal conviction and addresses more than $174 million in fraudulent Medicare claims involving multiple laboratories.
Read MorePosted by CLP Edit Staff | May 26, 2026 | Clinical Chemistry, Kidney Disease |
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Read More